Verition Fund Management LLC Takes $566,000 Position in Quintiles IMS Holdings Inc (Q)

Verition Fund Management LLC purchased a new position in Quintiles IMS Holdings Inc (NYSE:Q) during the second quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 6,328 shares of the medical research company’s stock, valued at approximately $566,000.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Vanguard Group Inc. grew its position in Quintiles IMS Holdings by 2.2% in the 2nd quarter. Vanguard Group Inc. now owns 12,789,723 shares of the medical research company’s stock valued at $1,144,680,000 after acquiring an additional 280,893 shares during the last quarter. Glenview Capital Management LLC grew its position in Quintiles IMS Holdings by 29.3% in the 2nd quarter. Glenview Capital Management LLC now owns 8,921,356 shares of the medical research company’s stock valued at $798,461,000 after acquiring an additional 2,023,719 shares during the last quarter. Longview Partners Guernsey LTD grew its position in Quintiles IMS Holdings by 6.2% in the 2nd quarter. Longview Partners Guernsey LTD now owns 8,711,447 shares of the medical research company’s stock valued at $779,675,000 after acquiring an additional 505,526 shares during the last quarter. Janus Capital Management LLC grew its position in Quintiles IMS Holdings by 0.4% in the 1st quarter. Janus Capital Management LLC now owns 7,783,546 shares of the medical research company’s stock valued at $626,804,000 after acquiring an additional 27,675 shares during the last quarter. Finally, Janus Henderson Group PLC grew its position in Quintiles IMS Holdings by 33,092.0% in the 2nd quarter. Janus Henderson Group PLC now owns 6,531,857 shares of the medical research company’s stock valued at $584,601,000 after acquiring an additional 6,512,178 shares during the last quarter. 93.27% of the stock is currently owned by institutional investors and hedge funds.

Shares of Quintiles IMS Holdings Inc (Q) traded up 2.07% on Friday, hitting $107.68. The stock had a trading volume of 373,933 shares. Quintiles IMS Holdings Inc has a 52-week low of $70.10 and a 52-week high of $108.43. The firm’s 50-day moving average price is $97.06 and its 200 day moving average price is $90.20. The firm has a market cap of $23.32 billion, a PE ratio of 312.12 and a beta of 0.62.

Quintiles IMS Holdings (NYSE:Q) last posted its quarterly earnings results on Thursday, October 26th. The medical research company reported $1.19 EPS for the quarter, topping the Zacks’ consensus estimate of $1.14 by $0.05. Quintiles IMS Holdings had a return on equity of 4.55% and a net margin of 3.45%. The business had revenue of $2.02 billion during the quarter, compared to the consensus estimate of $2.01 billion. During the same period last year, the firm earned $1.00 earnings per share. The company’s revenue for the quarter was up 77.6% compared to the same quarter last year. On average, equities research analysts predict that Quintiles IMS Holdings Inc will post $4.58 EPS for the current year.

WARNING: This piece of content was originally reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this piece of content on another site, it was illegally stolen and republished in violation of US and international copyright legislation. The correct version of this piece of content can be read at https://www.dispatchtribunal.com/2017/10/27/verition-fund-management-llc-buys-new-stake-in-quintiles-transitional-holdings-inc-q.html.

In other Quintiles IMS Holdings news, insider Kevin C. Knightly sold 20,000 shares of Quintiles IMS Holdings stock in a transaction that occurred on Wednesday, August 9th. The stock was sold at an average price of $90.28, for a total value of $1,805,600.00. Following the completion of the transaction, the insider now directly owns 46,826 shares in the company, valued at $4,227,451.28. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider James H. Erlinger III sold 10,000 shares of Quintiles IMS Holdings stock in a transaction that occurred on Wednesday, October 18th. The shares were sold at an average price of $100.51, for a total value of $1,005,100.00. Following the completion of the transaction, the insider now owns 27,340 shares of the company’s stock, valued at $2,747,943.40. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 14,208,382 shares of company stock valued at $1,362,839,475. 6.40% of the stock is currently owned by insiders.

A number of equities analysts have recently issued reports on Q shares. Robert W. Baird raised Quintiles IMS Holdings from an “underperform” rating to a “neutral” rating and increased their price target for the stock from $76.00 to $93.00 in a research report on Friday, July 7th. Zacks Investment Research raised Quintiles IMS Holdings from a “hold” rating to a “buy” rating and set a $101.00 price target on the stock in a research report on Thursday, July 27th. Barclays PLC reissued an “overweight” rating and set a $98.00 price target (up previously from $90.00) on shares of Quintiles IMS Holdings in a research report on Monday, July 17th. Royal Bank Of Canada initiated coverage on Quintiles IMS Holdings in a research report on Tuesday, September 19th. They set an “outperform” rating and a $116.00 price target on the stock. Finally, Argus raised their price objective on Quintiles IMS Holdings from $98.00 to $104.00 and gave the company a “buy” rating in a research report on Monday, September 18th. Ten analysts have rated the stock with a hold rating, ten have issued a buy rating and one has given a strong buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and a consensus price target of $96.77.

About Quintiles IMS Holdings

Quintiles IMS Holdings, Inc, formerly Quintiles Transnational Holdings Inc, provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offerings include national information offerings, sub-national information offerings, technology solutions, and workflow analytics and consulting services.

Institutional Ownership by Quarter for Quintiles IMS Holdings (NYSE:Q)

Receive News & Ratings for Quintiles IMS Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quintiles IMS Holdings Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply